Td Waterhouse Canada Inc. Ab Cellera Biologics Inc. Transaction History

Td Waterhouse Canada Inc.

$15.3 Trillion
Q3 2025

A detailed history of Td Waterhouse Canada Inc. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 24,538 shares of ABCL stock, worth $90,545. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,538

Previous 23,353 5.07%

Holding current value

$90,545

Previous $81.3 Million 80.04%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	BUY	$3.49 - $5.15 $4,135 - $6,102	1,185 Added 5.07%	24,538 $146 Million
Q2 2025 Aug 11, 2025	SELL	$1.93 - $3.8 $167 - $330	-87 Reduced 0.37%	23,353 $81.3 Million
Q1 2025 May 09, 2025	SELL	$2.2 - $3.53 $178,538 - $286,473	-81,154 Reduced 77.59%	23,440 $48.7 Million
Q4 2024 Feb 13, 2025	SELL	$2.48 - $3.15 $317,018 - $402,664	-127,830 Reduced 55.0%	104,594 $306 Million
Q3 2024 Nov 12, 2024	SELL	$2.39 - $3.49 $31,500 - $45,998	-13,180 Reduced 5.37%	232,424 $595 Million

Q2 2024 Nov 12, 2024	SELL	$2.73 - $4.73 $46,459 - $80,495	-17,018 Reduced 6.48%	245,604 $681 Million
Q2 2024 Aug 02, 2024	BUY	$2.73 - $4.73 $11,739 - $20,339	4,300 Added 1.66%	262,622 $1.56 Billion
Q1 2024 May 10, 2024	BUY	$4.29 - $5.97 $823 - $1,146	192 Added 0.07%	258,322 $1.13 Billion
Q4 2023 Feb 12, 2024	SELL	$3.91 - $5.93 $279,451 - $423,823	-71,471 Reduced 21.68%	258,130 $1.58 Billion
Q3 2023 Nov 13, 2023	SELL	$4.6 - $7.95 $1.12 Million - $1.94 Million	-244,314 Reduced 42.57%	329,601 $1.52 Billion
Q2 2023 Nov 13, 2023	BUY	$5.66 - $7.59 $516,656 - $692,830	91,282 Added 18.91%	573,915 $4.24 Billion
Q1 2023 Nov 13, 2023	SELL	$7.31 - $11.18 $226,105 - $345,808	-30,931 Reduced 6.02%	482,633 $4.25 Billion
Q4 2022 Nov 13, 2023	SELL	$9.48 - $14.52 $133,630 - $204,673	-14,096 Reduced 2.67%	513,564 $5.77 Billion
Q3 2022 Nov 13, 2023	BUY	$9.2 - $13.68 $1.59 Million - $2.37 Million	173,184 Added 48.86%	527,660 $6.36 Billion
Q2 2022 Nov 13, 2023	SELL	$5.72 - $10.65 $12,298 - $22,897	-2,150 Reduced 0.6%	354,476 $4.55 Billion
Q1 2022 Nov 13, 2023	BUY	$7.46 - $14.14 $1.31 Million - $2.48 Million	175,671 Added 97.08%	356,626 $4.28 Billion
Q4 2021 Nov 13, 2023	BUY	$12.99 - $17.73 $2.35 Million - $3.21 Million	180,955 New	180,955 $2.84 Billion

Others Institutions Holding ABCL

# of Institutions

169

Shares Held

109M

Call Options Held

1.26M

Put Options Held

788K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $1.05B
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.

Account

Td Waterhouse Canada Inc. Ab Cellera Biologics Inc. Transaction History